More Danish life science acquisitions on the way
A survey of 33 Danish corporate finance advisors shows that capital funds are on the move and likely to buy more companies in 2015 than last year. A large number of exits in the life science segment indicate that activity will go up here as well.
BY STEFAN SINGH KAILAY
It looks like investment activity in the Danish life science sector is on the rise. Life science projects accounted for 76% of the total venture capital invested in Denmark in 2014 – an increase of 13% since 2013 – and the industry is set for additional tailwind.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
”There’s more money than there has been in years”
For abonnenter
Danish venture groups: We have turned a corner
For abonnenter
